Dynamic Advisor Solutions LLC Makes New Investment in AngioDynamics, Inc. (NASDAQ:ANGO)

Dynamic Advisor Solutions LLC purchased a new position in shares of AngioDynamics, Inc. (NASDAQ:ANGOFree Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 25,605 shares of the medical instruments supplier’s stock, valued at approximately $201,000. Dynamic Advisor Solutions LLC owned approximately 0.06% of AngioDynamics at the end of the most recent quarter.

Several other large investors have also made changes to their positions in ANGO. Gladius Capital Management LP acquired a new stake in shares of AngioDynamics during the 3rd quarter worth approximately $30,000. Point72 Hong Kong Ltd acquired a new stake in AngioDynamics in the first quarter valued at approximately $36,000. US Bancorp DE boosted its position in AngioDynamics by 63.3% in the second quarter. US Bancorp DE now owns 3,691 shares of the medical instruments supplier’s stock valued at $38,000 after buying an additional 1,431 shares in the last quarter. Quarry LP boosted its position in AngioDynamics by 227.4% in the first quarter. Quarry LP now owns 3,899 shares of the medical instruments supplier’s stock valued at $40,000 after buying an additional 2,708 shares in the last quarter. Finally, Lazard Asset Management LLC acquired a new stake in AngioDynamics in the third quarter valued at approximately $41,000. Institutional investors and hedge funds own 89.43% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on ANGO shares. HC Wainwright cut their target price on shares of AngioDynamics from $20.00 to $18.00 and set a “buy” rating on the stock in a research report on Monday, January 8th. Raymond James cut their price target on shares of AngioDynamics from $12.00 to $10.00 and set an “outperform” rating on the stock in a report on Tuesday, January 9th.

Check Out Our Latest Stock Analysis on ANGO

AngioDynamics Stock Performance

Shares of NASDAQ:ANGO opened at $5.27 on Tuesday. The firm has a market cap of $210.01 million, a PE ratio of -15.06 and a beta of 0.66. AngioDynamics, Inc. has a 52 week low of $5.26 and a 52 week high of $12.62. The firm’s fifty day moving average is $5.82 and its 200-day moving average is $6.57.

AngioDynamics (NASDAQ:ANGOGet Free Report) last released its earnings results on Friday, January 5th. The medical instruments supplier reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.04. The business had revenue of $79.07 million for the quarter, compared to analyst estimates of $81.65 million. AngioDynamics had a negative net margin of 4.28% and a negative return on equity of 1.78%. Sell-side analysts forecast that AngioDynamics, Inc. will post -0.44 EPS for the current year.

AngioDynamics Company Profile

(Free Report)

AngioDynamics, Inc provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease.

Further Reading

Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics, Inc. (NASDAQ:ANGOFree Report).

Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.